These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38081944)

  • 1. The ubiquitin thioesterase YOD1 ameliorates mutant Huntingtin induced pathology in Drosophila.
    Farkas A; Zsindely N; Nagy G; Kovács L; Deák P; Bodai L
    Sci Rep; 2023 Dec; 13(1):21951. PubMed ID: 38081944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
    Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the proteostasis network in Huntington's disease.
    Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
    Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartment-Dependent Degradation of Mutant Huntingtin Accounts for Its Preferential Accumulation in Neuronal Processes.
    Zhao T; Hong Y; Li S; Li XJ
    J Neurosci; 2016 Aug; 36(32):8317-28. PubMed ID: 27511006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
    Wang N; Gray M; Lu XH; Cantle JP; Holley SM; Greiner E; Gu X; Shirasaki D; Cepeda C; Li Y; Dong H; Levine MS; Yang XW
    Nat Med; 2014 May; 20(5):536-41. PubMed ID: 24784230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
    Akbergenova Y; Littleton JT
    J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.
    Ast A; Buntru A; Schindler F; Hasenkopf R; Schulz A; Brusendorf L; Klockmeier K; Grelle G; McMahon B; Niederlechner H; Jansen I; Diez L; Edel J; Boeddrich A; Franklin SA; Baldo B; Schnoegl S; Kunz S; Purfürst B; Gaertner A; Kampinga HH; Morton AJ; Petersén Å; Kirstein J; Bates GP; Wanker EE
    Mol Cell; 2018 Sep; 71(5):675-688.e6. PubMed ID: 30193095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrodin Improves the Activity of the Ubiquitin-Proteasome System and the Autophagy-Lysosome Pathway to Degrade Mutant Huntingtin.
    Sun H; Li M; Li Y; Zheng N; Li J; Li X; Liu Y; Ji Q; Zhou L; Su J; Huang W; Liu Z; Liu P; Zou L
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity.
    Lemarié FL; Caron NS; Sanders SS; Schmidt ME; Nguyen YTN; Ko S; Xu X; Pouladi MA; Martin DDO; Hayden MR
    Neurobiol Dis; 2021 Oct; 158():105479. PubMed ID: 34390831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington's Disease Model.
    Zsindely N; Nagy G; Siági F; Farkas A; Bodai L
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease.
    Rippin I; Bonder K; Joseph S; Sarsor A; Vaks L; Eldar-Finkelman H
    Neurobiol Dis; 2021 Jul; 154():105336. PubMed ID: 33753290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice.
    Caron NS; Banos R; Aly AE; Xie Y; Ko S; Potluri N; Anderson C; Black HF; Anderson LM; Gordon B; Southwell AL; Hayden MR
    Neurobiol Dis; 2022 May; 166():105652. PubMed ID: 35143966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
    Aron R; Pellegrini P; Green EW; Maddison DC; Opoku-Nsiah K; Oliveira AO; Wong JS; Daub AC; Giorgini F; Muchowski P; Finkbeiner S
    Nat Commun; 2018 Sep; 9(1):3191. PubMed ID: 30266909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.
    Hakim-Eshed V; Boulos A; Cohen-Rosenzweig C; Yu-Taeger L; Ziv T; Kwon YT; Riess O; Phuc Nguyen HH; Ziv NE; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18661-18669. PubMed ID: 32675242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
    Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
    Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.
    Singh BK; Vatsa N; Nelson VK; Kumar V; Kumar SS; Mandal SC; Pal M; Jana NR
    Mol Neurobiol; 2018 Aug; 55(8):6337-6346. PubMed ID: 29294248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea infusion alleviates neurodegeneration induced by mutant Huntingtin in
    Varga J; Dér NP; Zsindely N; Bodai L
    Nutr Neurosci; 2020 Mar; 23(3):183-189. PubMed ID: 29973113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.